May 2003
Volume 44, Issue 13
ARVO Annual Meeting Abstract  |   May 2003
Prospective Evaluation of the M2 Disposable 130 Head in 100 Consecutive LASIK Procedures
Author Affiliations & Notes
  • L.Z. Kleiman
    Ophthalmology, NYU Medical Center/MEETH, New York, NY, United States
  • A.J. Kanellopoulos
    Ophthalmology, Eye Institute, Athens, Greece, Manhattan Eye, Ear, and Throat Hospital, New York, NY, United States
  • Footnotes
    Commercial Relationships  L.Z. Kleiman, None; A.J. Kanellopoulos, None.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 2667. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      L.Z. Kleiman, A.J. Kanellopoulos; Prospective Evaluation of the M2 Disposable 130 Head in 100 Consecutive LASIK Procedures . Invest. Ophthalmol. Vis. Sci. 2003;44(13):2667.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: To evaluate the safety and efficacy of the 130 disposable head of the M2 microkeratome (Moria, France) in LASIK procedures. Methods: We evaluated pre-and post-operative refraction, total high order aberrations (RMSH) changes, flap thickness, diameter and quality, hinge length as well as any complications. Mean follow-up was 4 months (3-5). Results: The mean pre-operative sphere was - 5.25 D (-1.00 to -11.50) and the mean pre-operative cylinder was -1.50 (-0.25 to -4.25). At 3 months 92% of the eyes were 20/20, 47% 20/15 and 31% 20/10. 100% of eyes were within +/- 0.5D of the refractive goal at 3 months. Flap thickness was 145 microns +/- 17.5, flap diameter was 8.5 mm (+/- 0.40), hinge length was 4.05mm (+/- 0.35). RMSH increased only 34% post-op. Conclusions: The 130 disposable head for the M2 microkeratome appears to be safe and very effective in LASIK procedures.

Keywords: refractive surgery: LASIK • refractive surgery: other technologies 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.